<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Diagnostic et traitement des hypercholestérolémies familiales (HF) chez l'adulte: recommandations de la Nouvelle société française d'athérosclérose (NSFA); Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: Guidelines from the New French Society of Atherosclerosis (NSFA)</dc:title>
  <dc:creator>FARNIER, Michel</dc:creator>
  <dc:creator>BRUCKERT, Eric</dc:creator>
  <dc:creator>BOILEAU, Catherine</dc:creator>
  <dc:creator>KREMPF, Michel</dc:creator>
  <dc:relation>La Presse médicale (1983) -- Presse méd. (1983), CODEN PRMEEM, ISSN 0755-4982, Vol. 42 (6) , pp. 930-950</dc:relation>
  <dc:date>2013</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>French</dc:language>
  <dc:publisher>Masson</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>21 p. ; 121 ref</dc:format>
  <dc:subject xml:lang="fr">Dyslipémie</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Hyperlipoprotéinémie</dc:subject>
  <dc:subject xml:lang="fr">Maladie métabolique</dc:subject>
  <dc:subject xml:lang="fr">Pathologie de l'appareil circulatoire</dc:subject>
  <dc:subject xml:lang="fr">Pathologie des vaisseaux sanguins</dc:subject>
  <dc:subject xml:lang="fr">Adulte</dc:subject>
  <dc:subject xml:lang="fr">Athérosclérose</dc:subject>
  <dc:subject xml:lang="fr">Cholestérol</dc:subject>
  <dc:subject xml:lang="fr">Diagnostic</dc:subject>
  <dc:subject xml:lang="fr">Français</dc:subject>
  <dc:subject xml:lang="fr">Hypercholestérolémie</dc:subject>
  <dc:subject xml:lang="fr">Lipide</dc:subject>
  <dc:subject xml:lang="fr">Lipoprotéine</dc:subject>
  <dc:subject xml:lang="fr">Maladie héréditaire</dc:subject>
  <dc:subject xml:lang="fr">Recommandation</dc:subject>
  <dc:subject xml:lang="fr">Santé publique</dc:subject>
  <dc:subject xml:lang="fr">Société</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:coverage xml:lang="fr">Europe</dc:coverage>
  <dc:coverage xml:lang="fr">France</dc:coverage>
  <dc:subject xml:lang="en">Dyslipemia</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Hyperlipoproteinemia</dc:subject>
  <dc:subject xml:lang="en">Metabolic diseases</dc:subject>
  <dc:subject xml:lang="en">Cardiovascular disease</dc:subject>
  <dc:subject xml:lang="en">Vascular disease</dc:subject>
  <dc:subject xml:lang="en">Adult</dc:subject>
  <dc:subject xml:lang="en">Atherosclerosis</dc:subject>
  <dc:subject xml:lang="en">Cholesterol</dc:subject>
  <dc:subject xml:lang="en">Diagnosis</dc:subject>
  <dc:subject xml:lang="en">French</dc:subject>
  <dc:subject xml:lang="en">Hypercholesterolemia</dc:subject>
  <dc:subject xml:lang="en">Lipids</dc:subject>
  <dc:subject xml:lang="en">Lipoprotein</dc:subject>
  <dc:subject xml:lang="en">Genetic disease</dc:subject>
  <dc:subject xml:lang="en">Recommendation</dc:subject>
  <dc:subject xml:lang="en">Public health</dc:subject>
  <dc:subject xml:lang="en">Society</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:coverage xml:lang="en">Europe</dc:coverage>
  <dc:coverage xml:lang="en">France</dc:coverage>
  <dc:subject xml:lang="es">Dislipemia</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Hiperlipoproteinemia</dc:subject>
  <dc:subject xml:lang="es">Metabolismo patología</dc:subject>
  <dc:subject xml:lang="es">Aparato circulatorio patología</dc:subject>
  <dc:subject xml:lang="es">Vaso sanguíneo patología</dc:subject>
  <dc:subject xml:lang="es">Adulto</dc:subject>
  <dc:subject xml:lang="es">Ateroesclerosis</dc:subject>
  <dc:subject xml:lang="es">Colesterol</dc:subject>
  <dc:subject xml:lang="es">Diagnóstico</dc:subject>
  <dc:subject xml:lang="es">Francés</dc:subject>
  <dc:subject xml:lang="es">Hipercolesterolemia</dc:subject>
  <dc:subject xml:lang="es">Lípido</dc:subject>
  <dc:subject xml:lang="es">Lipoproteina</dc:subject>
  <dc:subject xml:lang="es">Enfermedad hereditaria</dc:subject>
  <dc:subject xml:lang="es">Recomendación</dc:subject>
  <dc:subject xml:lang="es">Salud pública</dc:subject>
  <dc:subject xml:lang="es">Sociedad</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:coverage xml:lang="es">Europa</dc:coverage>
  <dc:coverage xml:lang="es">Francia</dc:coverage>
  <dc:subject>002B01: Generalites / General aspects</dc:subject>
  <dc:subject>002B22A: Dyslipémies. Hyperlipoprotéinémies / Disorders of blood lipids. Hyperlipoproteinemia</dc:subject>
  <dc:subject>002B30A11: Divers / Miscellaneous</dc:subject>
  <dc:subject>760-L: Divers / Miscellaneous</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 27429566</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>